Search results
Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits
CNBC· 4 days agoCompany logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain...
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
Morningstar· 7 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Medicines Agency’s Committee for Medicinal Products for Human ...
TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
Zacks via Yahoo Finance· 2 days agoZacks Rank Teva currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks...
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks· 7 days agoFree Report) and Regeneron (REGN Quick QuoteREGN - Free Report) announced that the FDA extended the review period for a regulatory filing seeking label expansion for their blockbuster drug Dupixent ...
GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- GSK Plc shares plunged in the wake of a court ruling that the UK drugmaker, alongside...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 7 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the U.S. Food and Drug Administration (FDA) has extended by three months the target ...
FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
Benzinga· 6 days agoOn Friday, the FDA extended the target action date of priority review of supplemental application...
Head-To-Head Survey: Ionis Pharmaceuticals (NASDAQ:IONS) versus Nurix Therapeutics (NASDAQ:NRIX)
ETF DAILY NEWS· 2 days agoNurix Therapeutics (NASDAQ:NRIX – Get Free Report) and Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) are both medical companies, but which is the better stock? We ...
Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More
Zacks via Yahoo Finance· 7 days agoJ&J (JNJ) and Merck (MRK) announce the acquisitions of private biotechs. The FDA grants Priority...
FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
Benzinga via Yahoo Finance· 6 days agoOn Friday, the FDA extended the target action date of priority review of supplemental application...